Combotope Therapeutics - Crunchbase Company Profile & Funding

Overview

Combotope Therapeutics

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Combotope Therapeutics

CB Rank

424646

Providing truly tumor specific antibodies for cancer therapies

Founded

obfuscation

Private

Lundtofte, Hovedstaden, Denmark

www.combotopetherapeutics.com/

Pharmaceutical

Key People

Andreas Laustsen: Co-founder
Past Role: Innovation Forum, Founder of Copenhagen Branch

Details

Operating Status

Active

Company Type

For Profit

Founders

Andreas Laustsen, Klas Ola Blixt, Søren Nyboe Jakobsen

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Combotope Antibody Discovery Platform

A proprietary platform for identifying monoclonal antibodies targeting aberrant O-glycosylation in cancer cells, enabling selective binding to tumors while sparing healthy tissue.

iDEAL Platform

A proprietary antibody discovery platform designed to generate tumor-specific antibodies that bind exclusively to cancer cell antigens, avoiding healthy cells.